Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 14, 2020; 26(26): 3834-3850
Published online Jul 14, 2020. doi: 10.3748/wjg.v26.i26.3834
Published online Jul 14, 2020. doi: 10.3748/wjg.v26.i26.3834
Parameters | Before H. pylori eradication (n = 85) | After H. pylori eradication (n = 85) | P value |
Endoscopic atrophy1, n (%) | |||
Absent | 5 (5.9) | 4 (4.7) | 1.0 |
Antrum | 19 (22.4) | 19 (22.4) | 1.0 |
Antrum-predominant | 18 (21.2) | 12 (14.1) | 0.23 |
Corpus-predominant | 21 (24.7) | 23 (27.1) | 0.73 |
Pan-atrophy | 22 (25.9) | 27 (31.8) | 0.40 |
OLGA-scale, n (%) | |||
Stage 0 | 4 (4.7) | 4 (4.7) | 1.0 |
Stage 1 | 22 (25.9) | 28 (32.9) | 0.31 |
Stage 2 | 34 (40) | 23 (27.1) | 0.07 |
Stage 3 | 20 (23.5) | 25 (29.4) | 0.38 |
Stage 4 | 5 (5.9) | 5 (5.9) | 1.0 |
EGGIM-scale, n (%) | |||
0-2 | 47 (55.3) | 45 (52.9) | 0.76 |
3-4 | 21 (24.7) | 10 (11.8) | 0.03a |
5-6 | 12 (14.1) | 21 (24.7) | 0.08 |
7-8 | 4 (4.7) | 4 (4.7) | 1.0 |
9-10 | 1 (1.2) | 5 (5.9) | 0.21 |
OLGIM-scale, n (%) | |||
Stage 0 | 40 (47.1) | 29 (34.1) | 0.08 |
Stage 1 | 14 (16.5) | 17 (20) | 0.55 |
Stage 2 | 14 (16.5) | 14 (16.5) | 1.0 |
Stage 3 | 13 (15.3) | 18 (21.2) | 0.32 |
Stage 4 | 4 (4.7) | 7 (8.2) | 0.53 |
Gastritis at histology2, n (%) | |||
Quiescent | 0 | 81 (95.3) | < 0.0001b |
Mild | 19 (22.4) | 4 (4.7) | 0.001b |
Moderate | 46 (54.1) | 0 | < 0.0001b |
Severe | 20 (23.5) | 0 | < 0.0001b |
MALT-hyperplasia, n (%) | |||
Absent | 46 (54.1) | 82 (96.5) | < 0.0001b |
Mild | 25 (29.4) | 3 (3.5) | < 0.0001b |
Moderate | 11 (12.9) | 0 | 0.007b |
Severe | 3 (3.5) | 0 | 0.24 |
Histological LGD3, n (%) | |||
Absent | 70 (82.4) | 57 (67.1) | 0.02a |
On random biopsies | 15 (17.6) | 9 (10.6) | 0.19 |
On random + on lesions biopsies | 0 | 6 (7) | 0.03b |
Only on visible lesions | 0 | 13 (15.3) | 0.0001b |
- Citation: Panarese A, Galatola G, Armentano R, Pimentel-Nunes P, Ierardi E, Caruso ML, Pesce F, Lenti MV, Palmitessa V, Coletta S, Shahini E. Helicobacter pylori-induced inflammation masks the underlying presence of low-grade dysplasia on gastric lesions. World J Gastroenterol 2020; 26(26): 3834-3850
- URL: https://www.wjgnet.com/1007-9327/full/v26/i26/3834.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i26.3834